Meeting
2019 ASCO Annual Meeting
Multimodality liquid biopsy for early monitoring and outcome prediction in first-line metastatic HER2-negative breast cancer: Final results of the prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG)— COMET study.
Authors
Jean-Yves Pierga
Institut Curie, Paris, France
Jean-Yves Pierga , Amanda Silveira , Olivier Tredan , Marie-Laure Tanguy , Veronique Lorgis , Coraline Dubot , William Jacot , Anthony Goncalves , Marc Debled , Christelle Levy , Jean-Marc Ferrero , Christelle Jouannaud , Marie-Ange Mouret-Reynier , Florence Dalenc , Jerome Lemonnier , Frederique Berger , Charlotte Proudhon , Francois Clement Bidard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Clinical Trial Registration Number
NCT01745757
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3019)
DOI
10.1200/JCO.2019.37.15_suppl.3019
Abstract #
3019
Poster Bd #
11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinico-molecular characteristics associated with outcomes in breast cancer patients treated with CDK4/6 inhibitors: Results from the AURORA Molecular Screening Initiative.
First Author: Elisa Agostinetto
Poster
2020 ASCO Virtual Scientific Program
Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid biopsy.
First Author: Jing Shan Lim
Poster
2021 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of 275 male breast cancer (BC) tissue (TBx) and liquid (LBx) biopsies: Comparative analysis to a female cohort (FBC) and therapeutic considerations.
First Author: Arun Kadamkulam Syriac
